Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$58.9M
+13.0% from 2023
Prescriptions
2,952
$19,944.16 per claim
Patients
406
467 prescribers
Total spending, 2024
$58.9M
$145,012.68 per patient
Medicare prescription drug plans paid $58.9M for Xalkori in 2024, for 2,952 prescriptions and refills to 406 patients (up 13.0% from 2023). The average cost per claim was $19,944.16.
California had the highest Medicare cost for Xalkori in 2024: $7.6M for 389 claims, followed by New York ($6.5M).
Jiahuai Tan, hematology-oncology in Mount Vernon, NY, had the highest Medicare cost for Xalkori in 2024: 25 claims costing $580K.
Xalkori is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm, Pfizer Labs..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jiahuai Tan Mount Vernon, NY | Hematology-Oncology | 25 | Under 11 | $580K |
| Alexander Edward D Drilon New York, NY | Medical Oncology | 24 | Under 11 | $580K |
| Daniel M Buroker |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 536 | 3,161 | 496 | $58.6M |
| 2023 | 438 | 2,601 | 386 | $52.1M |
| 2024 | 467 | 2,952 | 406 | $58.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 20 |
| Under 11 |
| $458K |
| Jeanne G Vaughn Boston, MA | Nurse Practitioner | 20 | Under 11 | $430K |
| Marilyn S Norton Chula Vista, CA | Hematology-Oncology | 24 | Under 11 | $404K |
| Sreenivas V Rao Florence, SC | Hematology-Oncology | 14 | Under 11 | $308K |
| Kanishka Chakraborty Kingsport, TN | Medical Oncology | 15 | Under 11 | $301K |
| Sarada Gurubhagavatula Florham Park, NJ | Medical Oncology | 13 | Under 11 | $297K |
| Kristen M Wright Camden, NJ | Nurse Practitioner | 13 | Under 11 | $297K |
| Kalust Ucar Glendale, CA | Hematology-Oncology | 13 | Under 11 | $295K |
| Matthew C Dugan Westbrook, ME | Medical Oncology | 12 | Under 11 | $293K |
| Thomas P O'Connor Jr. Weymouth, MA | Hematology-Oncology | 13 | Under 11 | $291K |
| Jody C Chuang Los Angeles, CA | Hematology-Oncology | 14 | Under 11 | $289K |
| Patrick Forde Baltimore, MD | Medical Oncology | 14 | Under 11 | $288K |
| Amy Rothrock State College, PA | Physician Assistant | 13 | Under 11 | $287K |
| Saba Radhi Gilbert, AZ | Medical Oncology | 11 | Under 11 | $287K |
| Ronjay Rakkhit Houston, TX | Hematology-Oncology | 13 | Under 11 | $286K |
| Nassim H Nabbout Wichita, KS | Hematology-Oncology | 13 | Under 11 | $283K |
| Benjamin Creelan Tampa, FL | Medical Oncology | 13 | Under 11 | $283K |
| Bruce H Saidman Kingston, PA | Medical Oncology | 12 | Under 11 | $283K |
| Gregory J Riely New York, NY | Medical Oncology | 14 | Under 11 | $278K |
| Thomas H Fong Saint Louis, MO | Hematology-Oncology | 12 | Under 11 | $278K |
| Luis E Raez Pembroke Pines, FL | Medical Oncology | 13 | Under 11 | $277K |
| Ian C Horkheimer Little Silver, NJ | Hematology-Oncology | 12 | Under 11 | $275K |
| Stephen Liu Los Angeles, CA | Hematology-Oncology | 12 | Under 11 | $275K |
Spending by manufacturer as listed in the spending data